Cargando…

FLT4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia

Treating patients with refractory acute myeloid leukemia (AML) remains challenging. Currently there is no effective treatment for refractory AML. Increasing evidence has demonstrated that refractory/relapsed AML is associated with leukemic blasts which can confer resistance to anticancer drugs. We h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Yoon, Lee, Sung-Eun, Han, A-Reum, Lee, Jongeun, Yoon, Young-sup, Kim, Hee-Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620598/
https://www.ncbi.nlm.nih.gov/pubmed/37317880
http://dx.doi.org/10.3324/haematol.2022.282472